Letters

NICE clinical guidelines: Maybe health economists should participate in guideline development

BMJ 2004; 329 doi: http://dx.doi.org/10.1136/bmj.329.7465.571 (Published 02 September 2004) Cite this as: BMJ 2004;329:571
  1. Peter Littlejohns, clinical director ([email protected]),
  2. Gillian Leng, guidelines programme director,
  3. Tony Culyer, chief scientist,
  4. Mike Drummond, director
  1. National Institute for Clinical Excellence, London WC1V 6NA
  2. National Institute for Clinical Excellence, London WC1V 6NA
  3. Institute for Work and Health, Toronto
  4. Centre for Health Economics, University of York

    EDITOR—Wailoo et al highlight a fundamental challenge that the National Institute for Clinical Excellence (NICE) faces on a daily basis.1 The government established NICE not only to advise the NHS on the quality of care that individual patients could expect (in terms of appropriateness and effectiveness) but also to address the other important dimensions of healthcare quality (equity, fairness, and efficiency) that society expects.

    We agree that being required to address both …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe